Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boehringer ingelheim
clinical trials
eli lilly
empagliflozin
1
×
europe
1
×
europe blog main
europe top stories
fda
1
×
indiana blog main
indiana top stories
life sciences
national blog main
new york blog main
new york top stories
slgt2 inhibitor
type 1 diabetes
type 2 diabetes
What
approval
bid
boehringer
diabetes
drug
1
×
eli
expand
fallen
fda
ingelheim
1
×
lilly
marketed
medicine’s
patients
1
×
rejects
short
type
Language
unset
Current search:
patients
×
europe
×
empagliflozin
×
drug
×
fda
×
ingelheim
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes